FLUDEOXYGLUCOSE F18

Post-LOE

fludeoxyglucose f-18

Innova Therapeutics
ANDAINTRAVENOUSINJECTABLE
Approved
Oct 2014
Lifecycle
Post-LOE
Competitive Pressure
30/100
Company
IT
Innova Therapeutics
SC - Mt. Pleasant
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers